# FDA Inspection 1182341 - Samchundang Pharm Co., Ltd. - October 27, 2022

Source: https://www.keypedia.com/records/fda_inspections/samchundang-pharm-co-ltd/fe953692-aab1-43f0-8f63-2b7e23800df8
Source feed: FDA_Inspections

> FDA Inspection 1182341 for Samchundang Pharm Co., Ltd. on October 27, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1182341
- Company Name: Samchundang Pharm Co., Ltd.
- Inspection Date: 2022-10-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1107697 - 2019-10-25](https://www.keypedia.com/records/fda_inspections/samchundang-pharm-co-ltd/714d4b85-4365-4913-981e-ad2f5b4379ec)
- [FDA Inspection 1024442 - 2017-09-08](https://www.keypedia.com/records/fda_inspections/samchundang-pharm-co-ltd/8e5c98f3-abb1-45a7-928d-8666e8f66aa0)

Company: https://www.keypedia.com/companies/samchundang-pharm-co-ltd/953048a3-14c3-475b-bebc-f43b8755905e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c